+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuropathy Pain Treatment Market by Treatment Type, Distribution Channel, Route of Administration, End User, Patient Demographics - Global Forecast to 2030- Product Image
Neuropathy Pain Treatment Market by Treatment Type, Distribution Channel, Route of Administration, End User, Patient Demographics - Global Forecast to 2030- Product Image
Sale

Neuropathy Pain Treatment Market by Treatment Type, Distribution Channel, Route of Administration, End User, Patient Demographics - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666258
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neuropathy pain treatment market is evolving rapidly, shaped by technological innovation, complex regulatory changes, and shifting patient preferences. Senior decision-makers face the challenge of anticipating market shifts while identifying resilient growth strategies across regions and technologies.

Market Snapshot: Neuropathy Pain Treatment Market

The Neuropathy Pain Treatment Market grew from USD 8.59 billion in 2024 to USD 9.64 billion in 2025. It is expected to continue growing at a CAGR of 11.63%, reaching USD 16.63 billion by 2030. Demand is rising as the incidence of neuropathic conditions increases, driven by aging demographics, chronic disease prevalence, and advances in therapy innovation. Growth in complementary and non-opioid treatments, as well as device-enabled interventions, is expanding options for both patients and providers in established and emerging regions.

Scope & Segmentation

This report provides a deep dive into all fundamental facets of the neuropathy pain treatment market, delivering a multi-dimensional segmentation that empowers strategic planning and investment.

  • Treatment Type: Complementary interventions (herbal supplements, mind-body techniques), devices (neuromodulation, peripheral nerve stimulation, spinal cord stimulation, TENS), pharmaceuticals (analgesics—non-opioid and opioid; anticonvulsants such as gabapentinoids; antidepressants including SNRIs and TCAs; and topical agents like capsaicin and lidocaine), and therapies (acupuncture, massage therapy, physical therapy).
  • Distribution Channel: Diverse pathways, including hospital pharmacy, online pharmacy, retail pharmacy, and specialty clinics (pain clinics, rehabilitation centers).
  • Route of Administration: Options encompass injectable (intravenous, subcutaneous), oral (capsules, tablets), topical (creams, gels), and transdermal (patches) methods.
  • End User: Ambulatory care centers (outpatient), clinics (pain and rehabilitation), home care settings, and hospitals.
  • Patient Demographics: Segmentation by age (adult, geriatric, pediatric) and gender, supporting tailored product strategies.
  • Regions Covered: Americas (United States—major states, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (incl. UK, Germany, France, Russia, UAE, South Africa, more); Asia-Pacific (China, India, Japan, Australia, and key SE Asian countries).
  • Technological Innovation: Focus on neuromodulation devices, digital health tools, non-opioid pharmaceuticals, and integrative therapies.
  • Company Analysis: Leading positions held by Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Viatris Inc., Endo International plc, Grünenthal GmbH, Novartis AG, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., and Sandoz International GmbH.

Key Takeaways: Strategic Insights for Senior Leaders

  • Integrated care leveraging pharmacological, device-based, and behavioral therapies is emerging as the new standard, supporting improved patient outcomes and diverse market opportunities.
  • Rising regulatory scrutiny of opioid therapies is accelerating demand for non-opioid analgesics and targeted anticonvulsants, reshaping prescription patterns and opening space for safer, innovative products.
  • Digital transformation, including telehealth and remote monitoring, is enhancing real-time patient management and supporting new engagement models for chronic pain care.
  • Patient-centric segmentation by age, gender, and care setting is enabling tailored marketing and product development, supporting value generation in both high-growth and mature markets.
  • Real-world evidence, data analytics, and outcome-based agreements are strengthening the commercial case with payers and aligning reimbursement with demonstrated clinical value.
  • Strategic partnerships and regional supply chain localization are becoming vital to navigate operational uncertainties and build long-term resilience.

Tariff Impact: United States Market Disruption

New U.S. tariffs in 2025 are increasing cost pressures for neuromodulation devices and drug ingredients, compelling manufacturers to adapt sourcing strategies and localize supply chains. These changes are influencing pricing, payer negotiations, and investment in domestic production, with downstream effects on patient access and competitive differentiation.

Methodology & Data Sources

Findings are underpinned by a rigorous methodology leveraging comprehensive secondary research, industry journals, regulatory filings, white papers, and company disclosures. Primary insights were validated by interviews with clinicians, payers, and advocacy leaders. Quantitative analyses integrate epidemiological and healthcare utilization data, triangulated and validated through expert peer review to ensure accuracy and relevance.

Why This Report Matters

  • Enables executives to benchmark competitive positioning, anticipate market shifts, and allocate resources in alignment with evolving patient and regulatory demands.
  • Provides actionable insights into technology adoption, regional market entry, and payer engagement—supporting evidence-based decision making for sustainable growth.
  • Equips stakeholders with credible market segmentation and trend analysis to optimize commercial strategy and innovation roadmaps.

Conclusion

The neuropathy pain treatment market is transforming, offering leaders meaningful opportunities to capitalize on innovation, regional growth, and tailored patient solutions. This report serves as a critical guide for informed strategy and leadership in a fast-evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuropathy Pain Treatment Market, by Treatment Type
8.1. Introduction
8.2. Complementary
8.2.1. Herbal Supplements
8.2.2. Mind Body Techniques
8.3. Device
8.3.1. Neuromodulation
8.3.1.1. Peripheral Nerve Stimulation
8.3.1.2. Spinal Cord Stimulation
8.3.2. TENS
8.4. Drug
8.4.1. Analgesics
8.4.1.1. Non-Opioids
8.4.1.2. Opioids
8.4.2. Anticonvulsants
8.4.2.1. Gabapentinoids
8.4.3. Antidepressants
8.4.3.1. SNRIs
8.4.3.2. TCAs
8.4.4. Topical Agents
8.4.4.1. Capsaicin
8.4.4.2. Lidocaine
8.5. Therapy
8.5.1. Acupuncture
8.5.2. Massage Therapy
8.5.3. Physical Therapy
9. Neuropathy Pain Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
9.5. Specialty Clinic
9.5.1. Pain Clinics
9.5.2. Rehabilitation Centers
10. Neuropathy Pain Treatment Market, by Route of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intravenous
10.2.2. Subcutaneous
10.3. Oral
10.3.1. Capsules
10.3.2. Tablets
10.4. Topical
10.4.1. Creams
10.4.2. Gels
10.5. Transdermal
10.5.1. Patches
11. Neuropathy Pain Treatment Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.2.1. Outpatient Centers
11.3. Clinic
11.3.1. Pain Clinic
11.3.2. Rehabilitation Center
11.4. Home Care
11.5. Hospital
12. Neuropathy Pain Treatment Market, by Patient Demographics
12.1. Introduction
12.2. Age Group
12.2.1. Adult
12.2.2. Geriatric
12.2.3. Pediatric
12.3. Gender
12.3.1. Female
12.3.2. Male
13. Americas Neuropathy Pain Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Neuropathy Pain Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Neuropathy Pain Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Eli Lilly and Company
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Viatris Inc.
16.3.5. Endo International plc
16.3.6. Grünenthal GmbH
16.3.7. Novartis AG
16.3.8. Astellas Pharma Inc.
16.3.9. Sun Pharmaceutical Industries Ltd.
16.3.10. Sandoz International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NEUROPATHY PAIN TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. NEUROPATHY PAIN TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. NEUROPATHY PAIN TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NEUROPATHY PAIN TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NEUROPATHY PAIN TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROPATHY PAIN TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MIND BODY TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GABAPENTINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SNRIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TCAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSAICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MASSAGE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REHABILITATION CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 132. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 134. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 135. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 136. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 137. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 138. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 139. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 140. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 141. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 142. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 144. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 146. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 147. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 148. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 149. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 151. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 152. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 153. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 157. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 158. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 159. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 160. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 165. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 167. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 169. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 170. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 171. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 172. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 174. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 175. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 271. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 272. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 273. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 274. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 275. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 276. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 277. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 278. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 279. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 280. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 281. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 283. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 285. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 286. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 287. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 288. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 290. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 291. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 294. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 295. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 296. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 297. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 298. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 299. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 300. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2030 (USD MILLION)
TABLE 301. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 302. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 303. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 304. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, 2018-2030 (USD MILLION)
TABLE 306. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 308. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 309. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 310. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 311. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 313. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 314. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 315. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 316. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 317. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2030 (USD MILLION)
TABLE 319. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 320. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2030 (USD MILLION)
TABLE 321. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 322. RUSSIA NEUROPATHY PAIN TREATMENT MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neuropathy Pain Treatment market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Endo International plc
  • Grünenthal GmbH
  • Novartis AG
  • Astellas Pharma Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.63 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diabetic Neuropathy Market by Drug Class, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Diabetic Neuropathy Market by Drug Class, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Diabetic Neuropathic Pain Market Report and Forecast 2025-2034 - Product Image

Diabetic Neuropathic Pain Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Treatment Market by Treatment Type, Route of Administration, Patient Age Group, Therapy Duration, End-User - Global Forecast to 2030 - Product Image

Chemotherapy Induced Peripheral Neuropathy Treatment Market by Treatment Type, Route of Administration, Patient Age Group, Therapy Duration, End-User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Diabetic Neuropathy Management Market Size, Share & Trends Analysis Report By Devices (Electrical stimulation, Neuro Stimulation Devices), By Application (Peripheral Neuropathy), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Diabetic Neuropathy Management Market Size, Share & Trends Analysis Report By Devices (Electrical stimulation, Neuro Stimulation Devices), By Application (Peripheral Neuropathy), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 220 Pages
  • Global
From
Diabetic Neuropathic Pain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Diabetic Neuropathic Pain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Neuropathy Pain Drug Market

The Neuropathy Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathy Pain Drugs are used to treat the pain associated with peripheral neuropathy, a condition caused by damage to the peripheral nervous system. These drugs are typically prescribed to patients with diabetes, HIV, and chemotherapy-induced neuropathy. Commonly prescribed Neuropathy Pain Drugs include anticonvulsants, antidepressants, and opioids. The Neuropathy Pain Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, and Merck & Co. Other companies in the market include AbbVie, AstraZeneca, Eli Lilly, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.